Results 11 to 20 of about 29,631 (205)

Influence of a Heterologous (ChAdOx1-nCoV-19/BNT162b2) or Homologous (BNT162b2/BNT162b2) Vaccination Regimen on the Antibody and T Cell Response to a Third Vaccination with BNT162b2

Vaccines, 2022
Emerging numbers of SARS-CoV-2 infections are currently combated with a third vaccination. Considering the different vaccination regimens used for the first two vaccine doses, we addressed whether the previous vaccination influences the immune response ...
Geßner, Reinhard, Mutters, Reinier, Von Blanckenburg, Pia, Thiemer, Julia, Pia Von Blanckenburg, Reiter, Rieke, Rieke Reiter, Ulf Seifart, Seifart, Ulf, Julia Thiemer, Reinhard Geßner, Reinier Mutters   +11 more
core   +5 more sources

Immunogenicity and efficacy of heterologous ChAdOx1-BNT162b2 vaccination [PDF]

Nature, 2021
Following severe adverse reactions to the AstraZeneca ChAdOx1-S-nCoV-19 vaccine1,2, European health authorities recommended that patients under the age of 55?years who received one dose of ChAdOx1-S-nCoV-19 receive a second dose of the Pfizer BNT162b2 ...
Lina, Bruno, Andrieu, Thibault, Allatif, Omran, Djebali, Sophia, Walzer, Thierry, Brengel-Pesce, Karen, Legros, Vincent, Cosset, François-Loïc, Boson, Bertrand, Bal, Antonin, Guibert, Nicolas, Bourlet, Thomas, Trouillet-Assant, Sophie, Valette, Martine, Marvel, Jacqueline, Villard, Marine, Peyrot, Loïc, Paul, Stéphane, Denolly, Solène, Fassier, Jean-Baptiste, Pozzetto, Bruno, Massardier-Pilonchery, Amélie, Yaugel-Novoa, Melyssa, Barateau, Véronique, Defrance, Thierry   +24 more
core   +6 more sources

Anti-spike antibody trajectories in individuals previously immunised with BNT162b2 or ChAdOx1 following a BNT162b2 booster dose [PDF]

Wellcome Open Research, 2022
Background: The two most common SARS-CoV-2 vaccines in the UK, BNT162b2 (Pfizer-BioNTech) and ChAdOx1 nCoV-19 (Oxford-AstraZeneca), employ different immunogenic mechanisms.
Fong, Wing Lam Erica, Braithwaite, Isobel, Aldridge, Robert W, Hayward, Andrew, Hoskins, Susan, Andrew Hayward, Wing Lam Erica Fong, Geismar, Cyril, Byrne, Thomas, Kovar, Jana, Alexei Yavlinsky, Sarah Beale, Annalan M D Navaratnam, Jana Kovar, Navaratnam, Annalan MD, Patel, Parth, Fragaszy, Ellen, Nguyen, Vincent, Madhumita Shrotri, Vincent Nguyen, Shrotri, Madhumita, Isobel Braithwaite, Thomas Byrne, Susan Hoskins, Parth Patel, Cyril Geismar, Ellen Fragaszy, Robert W Aldridge, Yavlinsky, Alexei, Beale, Sarah   +29 more
core   +5 more sources

Heterologous ChAdOx1-BNT162b2 vaccination in Korean cohort induces robust immune and antibody responses that includes Omicron

iScience, 2022
Summary: Heterologous ChAdOx1-BNT162b2 vaccination induces a stronger immune response than BNT162b2-BNT162b2. Here, we investigated the molecular transcriptome, germline allelic variants of immunoglobulin loci, and anti-Omicron antibody levels in 46 ...
Hye Kyung Lee, Jinyoung Go, Heungsup Sung, Seong Who Kim, Mary Walter, Ludwig Knabl, Priscilla A. Furth, Lothar Hennighausen, Jin Won Huh   +8 more
doaj   +2 more sources

Adverse Reactions after BNT162b2 Messenger RNA Vaccination for Coronavirus Disease 2019 in Healthcare Workers Compared with Influenza Vaccination

Vaccines, 2023
This study aimed to compare adverse reactions following BNT162b2 and influenza vaccinations in healthcare workers. This study included healthcare workers who received the BNT162b2 vaccine and/or inactivated influenza vaccine, quadrivalent (IIV4), on 18 ...
A-Sol Kim, Sung-Min Kim, Ji-Eun Song, Soyoon Hwang, Eunkyung Nam, Ki Tae Kwon   +5 more
doaj   +2 more sources

Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line

Current Issues in Molecular Biology, 2022
Preclinical studies of COVID-19 mRNA vaccine BNT162b2, developed by Pfizer and BioNTech, showed reversible hepatic effects in animals that received the BNT162b2 injection.
Markus Aldén, Francisko Olofsson Falla, Daowei Yang, Mohammad Barghouth, Cheng Luan, Magnus Rasmussen, Yang De Marinis   +6 more
doaj   +3 more sources

Acute myocarditis following administration of BNT162b2 vaccine

IDCases, 2021
The wide use of vaccines was linked with rare but serious complications in adults, causing a global concern. Here, we describe a young male patient, who presented with acute myocarditis, three days after the second dose of BNT162b2 ...
Mawahib Elhassan, Ahmed Elyas (17280673), Mhd Baraa Habib, Tahseen Hamamyh, Ahmed Elyas, Mhd Baraa Habib (11721774), Mohammed Altermanini (17280676), Mawahib Elhassan (14777326), Tahseen Hamamyh (16810761), Mohammed Altermanini   +9 more
core   +4 more sources

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.

New England Journal of Medicine, 2020
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the resulting coronavirus disease 2019 (Covid-19) have afflicted tens of millions of people in a worldwide pandemic.
Nell, Haylene, Hammitt, Laura L, Polack, Fernando P., Dormitzer, Philip R., Moreira, Edson D., Lockhart, Stephen, Koury, Kenneth, Pérez Marc, Gonzalo, Ünal, Serhat, Schaefer, Axel, Absalon, Judith, Roychoudhury, Satrajit, Hammitt, Laura L., Frenck, Robert W., Zerbini, Cristiano, Frenck, Robert W, Bailey, Ruth, Mather, Susan, Swanson, Kena A., Tresnan, Dina B., Thomas, Stephen J, Moreira, Edson D, Jansen, Kathrin U, Gruber, William C, Kalina, Warren V., Li, Ping, Gurtman, Alejandra, Polack, Fernando P, Swanson, Kena A, Jansen, Kathrin U., Perez, John L., Türeci, Özlem, Yozviak, Joseph L, DO, FACP, Perez, John L, Kitchin, Nicholas, Gruber, William C., Kalina, Warren V, Thomas, Stephen J., Tresnan, Dina B, Şahin, Uğur, Cooper, David, Dormitzer, Philip R   +41 more
core   +3 more sources

Booster Vaccination with BNT162b2 Improves Cellular and Humoral Immune Response in the Pediatric Population Immunized with CoronaVac

Vaccines
The SARS-CoV-2 Omicron variant and its sublineages continue to cause COVID-19-associated pediatric hospitalizations, severe disease, and death globally. BNT162b2 and CoronaVac are the main vaccines used in Chile.
Diego A. Díaz-Dinamarca, Simone Cárdenas-Cáceres, Nicolás A. Muena, Pablo Díaz, Gisselle Barra, Rodrigo Puentes, Daniel F. Escobar, Michal Díaz-Samirin, Natalia T. Santis-Alay, Cecilia Canales, Janepsy Díaz, Heriberto E. García-Escorza, Alba Grifoni, Alessandro Sette, Nicole D. Tischler, Abel E. Vasquez   +15 more
doaj   +2 more sources

Beyond neutralization for BNT162b2 mRNA vaccination [PDF]

Cell Host & Microbe, 2021
Mounting a robust immune response against SARS-CoV-2 requires neutralization as well as effector T cell functions. In this issue of Cell Host Microbe, Tauzin et al. characterize the humoral and T cell responses after a single dose of BNT162b2 mRNA vaccine in individuals with or without previous exposure to SARS-CoV-2.
Damani-Yokota, Payal, Yeung, Stephen T., Khanna, Kamal M.   +2 more
openaire   +2 more sources